Toxocara canis: Difference between revisions
No edit summary |
(Text replacement - "OR" to "'''OR'''") |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 12: | Line 12: | ||
==Management== | ==Management== | ||
*Diethylcarbamazine | *Diethylcarbamazine 6mg/kg/day divided TID x 7-10 days '''OR''' mebendazole 100-200mg BID x 5 days '''OR''' albendazole 400mg BID x 3-5 days | ||
==Disposition== | ==Disposition== | ||
| Line 23: | Line 23: | ||
==External Links== | ==External Links== | ||
== | ==References== | ||
<references/> | <references/> | ||
[[Category:ID]] | [[Category:ID]] | ||
[[Category: | [[Category:Tropical Medicine]] | ||
Latest revision as of 22:51, 30 May 2017
Background
Clinical Features
- Visceral toxocariasis (visceral larva migrans)
- Larvae travel through liver / lungs / CNS causing fever, cough, enlarged liver, pneumonia
- Ocular toxocariasis (ocular larva migrans)
- Larvae travel to the eye causing inflammation and scarring of retina, usually only one eye, irreversible vision loss
Differential Diagnosis
Workup
Management
- Diethylcarbamazine 6mg/kg/day divided TID x 7-10 days OR mebendazole 100-200mg BID x 5 days OR albendazole 400mg BID x 3-5 days